Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 52 EUR 0.19% Market Closed
Market Cap: 10.7B EUR
Have any thoughts about
Recordati Industria Chimica e Farmaceutica SpA?
Write Note

Wall Street
Price Targets

REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA

Wall Street analysts forecast REC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REC is 55.49 EUR with a low forecast of 45.45 EUR and a high forecast of 66.15 EUR.

Lowest
Price Target
45.45 EUR
13% Downside
Average
Price Target
55.49 EUR
7% Upside
Highest
Price Target
66.15 EUR
27% Upside
Recordati Industria Chimica e Farmaceutica SpA Competitors:
Price Targets
1666
Tong Ren Tang Technologies Co Ltd
30% Upside
BMY
Bristol-Myers Squibb Co
8% Downside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
20% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
22% Upside
VRNA
Verona Pharma PLC
8% Upside
OGI
OrganiGram Holdings Inc
77% Upside
2096
Simcere Pharmaceutical Group Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 10%.

9%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 13%.

9%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 16%.

9%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REC's stock price target?
Price Target
55.49 EUR

According to Wall Street analysts, the average 1-year price target for REC is 55.49 EUR with a low forecast of 45.45 EUR and a high forecast of 66.15 EUR.

What is Recordati Industria Chimica e Farmaceutica SpA's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 10%.

What is Recordati Industria Chimica e Farmaceutica SpA's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 13%.

What is Recordati Industria Chimica e Farmaceutica SpA's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 16%.

Back to Top